Identification and mapping of linear antigenic determinants of human amyloid β(1-42) peptide

Journal of Immunoassay and Immunochemistry

Volumn 33, Issue 1, 2012, Pages 26-34

  Subramanian, Sarada ^a   D'Souza, Regina ^a   Divya Shree, A N ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Alzheimer's disease; amyloid ; minivaccine; peptide

Indexed keywords

ALZHEIMER DISEASE VACCINE; AMYLOID BETA PROTEIN[1-16]; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[13-28]; AMYLOID BETA PROTEIN[20-35]; AMYLOID BETA PROTEIN[27-42]; AMYLOID BETA PROTEIN[7-22]; EPITOPE; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANTIGENIC MODULATION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EPITOPE MAPPING; FEMALE; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; TH1 CELL; TH2 CELL;

AMINO ACID SEQUENCE; AMYLOID BETA-PEPTIDES; ANTIBODIES; ANTIGEN-ANTIBODY REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; EPITOPES; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS;

EID: 84856280344     PISSN: 15321819     EISSN: 15324230     Source Type: Journal    
DOI: 10.1080/15321819.2011.591477     Document Type: Article

References (31)

1. Price, D. L.; Sisodia, S. S. Cellular and Molecular Biology of Alzheimer's Disease and Animal Models. Ann. Rev. Med. 1994, 45, 435-446. (Pubitemid 24158173)
2. Selkoe, D. J. Alzheimer's Disease: A Central Role for Amyloid. J. Neuropathol. Exp. Neurol. 1994, 53, 438-447. (Pubitemid 24276802)
3. Esler, W. P.; Wolfe, M. S. A Portrait of Alzheimer Secretases-New Features and Familial Faces. Science 2001, 293, 1449-1454. (Pubitemid 32801541)
4. Helmuth, L. New Therapies: New Alzheimer's Treatments that May Ease the Mind. Science 2002, 297, 1260-1262. (Pubitemid 34913141)
5. Cribbs, D. H.; Agadjanyan, M. G. Immunotherapy for Alzheimer's Disease: Potential Problems and Possible Solutions. Curr. Immunol. Rev. 2005, 1, 95.
6. Lemere, C. A.; Masliah, E. Can Alzheimer Disease be Prevented by Amyloid-β Immunotherapy? Nat. Rev. Neurol. 2010, 6, 108-119.
7. Schenk, D.; Barbour, R.; Dunn, W.; Gordon, G.; Grajeda, H.; Guido, T.; Hu, K.; Huang, J.; Johnson-Wood, K.; Khan, K.; Kholodenko, D.; Lee, M.; Liao, Z.; Lieberurg, I.; Motter, R.; Mutter, L.; Soriano, F.; Shopp, G.; Vasquez, N.; Vandevert, C.; Walker, S.; Wogulis, M.; Yednock, T.; Games, D.; Seubert, P. Immunization with Amyloid-beta Attenuates Alzheimer Disease-like Pathology in the PDAPP Mouse. Nature 1999, 400, 173-177. (Pubitemid 29327547)
8. Schenk, D. Opinion: Amyloid-β Immunotherapy for Alzheimer's Disease: The End of the Beginning. Nat. Rev. Neurosci. 2002, 3, 824.
9. Morgan, D.; Diamond, D. M.; Gottschall, P. E.; Ugen, K. E.; Dickey, C.; Hardy, J.; Duff, K.; Jantzen, P.; DiCarlo, G.; Wilcock, D.; Connor, K.; Hatcher, J.; Hope, C.; Gordon, M.; Arendash, G.W. Aβ Peptide Vaccination Prevents Memory Loss in an Animal Model of Alzheimer's Disease. Nature 2000, 408, 982-985. (Pubitemid 32101645)
10. Janus, C.; Chishti, M. A.; Westaway, D. Transgenic Mouse Models of Alzheimer's Disease. Biochim. Biophys. Acta 2000, 1502, 63-75. (Pubitemid 30433856)
11. Bard, F.; Cannon, C.; Barbour, R.; Burke, R. L.; Games, D.; Grajeda, H.; Guido, T.; Hu, K.; Huang, J.; Johnson-Wood, K.; Khan, K.; Kholodenko, D.; Lee, M.; Lieberburg, I.; Motter, R.; Nguyen, M.; Soriano, F.; Vasquez, N.; Weiss, K.; Welch, B.; Seubert, P.; Schenk, D.; Yednock, T. Peripherally Administered Antibodies Against Amyloid β-Peptide Enter the Central Nervous System and Reduce Pathology in a Mouse Model of Alzheimer Disease. Nat. Med. 2000, 6, 916-919. (Pubitemid 30644751)
12. DeMattos, R. B.; Bales, K. R.; Cummins, D. J.; Dodart, J. C.; Paul, S. M.; Holtzman, D. M. Peripheral Anti-Aβ Antibody Alters CNS and Plasma Aβ Clearance and Decreases Brain Aβ Burden in a Mouse Model of Alzheimer's Disease. Proc. Natl. Acad. Sci. USA 2001, 98, 8850-8855. (Pubitemid 32678116)
13. Cribbs, D. H.; Ghochikyan, A.; Vasilevko, V.; Tran, M.; Petrushina, I.; Sadzikava, N.; Babikyan, D.; Kesslak, P.; Kieber-Emmons, T.; Cotman, C. W.; Agadjanyan, M. G. Adjuvant-dependent Modulation of Th1 and Th2 Responses to Immunization with β-Amyloid. Int. Immunol. 2003, 15, 505-514. (Pubitemid 36432403)
14. Birmingham, K.; Frantz, S. Set Back Alzheimer Vaccine Studies. Nat. Med. 2002, 8, 199-200. (Pubitemid 34250084)
15. Ferrer, I.; Boada Rovira, M.; Sanchez Guerra, M. L.; Rey, M. J.; Costa-Jussa, F. Neuropathology and Pathogenesis of Encephalitis Following Amyloid-β Immunization in Alzheimer's Disease. Brain Pathol. 2004, 14, 11-20. (Pubitemid 38200585)
16. Nicoll, J. A.; Wilkinson, D.; Holmes, C.; Steart, P.; Markham, H.; Weller, R. O. Neuropathology of Human Alzheimer Disease after Immunization with Amyloid-β Peptide: A Case Report. Nat. Med. 2003, 9, 448-452. (Pubitemid 36460079)
17. Broytman, O.; Malter, J. S. Anti-Aβ: The Good, the Bad, and the Unforeseen. J. Neurosci. Res. 2004, 75, 301-306.
18. Subramanian, S.; Divya Shree, A. N. Enhanced Th2 Immunity after DNA Prime-Protein Boost Immunization with Amyloid β (1-42) plus CpG Oligodeoxynucleotides in Aged Rats. Neurosci. Lett. 2008, 436, 219-222.
19. Subramanian, S.; Bandopadhyay, D.; Mishra, P. K.; Mathew, M.; John, M. Design and Development of Non-fibrillar Amyloid β as a Potential Alzheimer Vaccine. Biochem. Biophys. Res. Commun. 2010, 394, 393-397.
20. Agadjanyan, M. G.; Ghochikyan, A.; Petrushina, I.; Vasilevko, V.; Movsesyan, N.; Mkrtichyan, M.; Saing, T.; Cribbs, D. H. Prototype Alzheimer's Disease Vaccine using the Immunodominant B Cell Epitope from β-amyloid and Promiscuous T cell Epitope Pan HLA DR-binding Peptide. J. Immunol. 2005, 174, 1580-1586.
21. Ghochikyan, A.; Mkrtichyan, M.; Petrushina, I.; Movsesyan, N.; Karapetyan, A.; Cribbs, D. H.; Agadjanyan, M. G. Prototype Alzheimer's Disease Epitope Vaccine Induced Strong Th2-type Anti-Aβ Antibody Response with Alum to Quil A Adjuvant Switch. Vaccine 2006, 24, 2275-2282. (Pubitemid 43290409)
22. Seabrook, T. J.; Thomas, K.; Jiang, L.; Bloom, J.; Spooner, E.; Maier, M.; Bitan, G.; Lemere, C. A. Dendrimeric Aβ1-15 is an Effective Immunogen in Wildtype and APP-tg Mice. Neurobiol. Aging 2007, 28, 813-823. (Pubitemid 46589741)
23. Subramanian, S.; Divya Shree, A. N. Expression, Purification and Characterization of a Synthetic Gene Encoding Human Amyloid β (Aβ1-42) in Escherichia coli. Indian J. Biochem. Biophys. 2007, 44, 71-75. (Pubitemid 47409445)
24. Ghochikyan, A.; Petrushina, I.; Lees, A.; Vasilevko, V.; Movsesyan, N.; Karapetyan, A.; Agadjanyan, M. G.; Cribbs, D. H. Aβ-immunotherapy for Alzheimer's Disease using Mannan-amyloid-beta Peptide Immunoconjugates. DNA Cell Biol. 2006, 25, 571-580. (Pubitemid 46141328)
25. 1-42 in Young and Aged Canines: Antibody Generation and Characteristics, and Effects on CSF and Brain Aβ. Vaccine 2006, 24, 2824-2834.
26. Maier, A. M.; Seabrook, T. J.; Lemere, C. A. Modulation of the Humoral and Cellular Immune Response in Aβ Immunotherapy by the Adjuvants Monophosphoryl Lipid A (MPL), Cholera Toxin B Subunit (CTB) and E. coli Enterotoxin LT (R192G). Vaccine 2005, 23, 5149-5159. (Pubitemid 41356545)
27. Lemere, C. A.; Maron, R.; Spooner, E. T.; Grenfell, T. J.; Mori, C.; Desai, R.; Hancock, W. W.; Weiner, H. L.; Selkoe, D. J. Nasal A Beta Treatment Induces Anti-A Beta Antibody Production and Decreases Cerebral Amyloid Burden in PD-APP Mice. Ann. N Y Acad. Sci. 2000, 920, 328-331. (Pubitemid 32056589)
28. Weiner, H. L.; Lemere, C. A.; Maron, R.; Spooner, E. T.; Grenfell, T. J.; Mori, C.; Issazadeh, S.; Hancock, W. W.; Selkoe, D. J. Nasal Administration of Amyloid-beta Peptide Decreases Cerebral Amyloid Burden in a Mouse Model of Alzheimer's Disease. Ann. Neurol. 2000, 48, 567-579.
29. Ghochikyan, A.; Vasilevko, V.; Petrushina, I.; Movsesyan, N.; Babikyan, D.; Tian, W.; Sadzikava, N.; Ross, T. M.; Head, E.; Cribbs, D. H.; Agadjanyan, M. G. Generation and Characterization of the Humoral Immune Response to DNA Immunization with a Chimeric β Amyloid-interleukin-4 Minigene. Eur. J. Immunol. 2003, 33, 3232-3241. (Pubitemid 37541099)
30. Monsego, A.; Maron, R.; Zota, V.; Selkoe, D. J.; Weiner, H. L. Immune Hyporesponsiveness to Amyloid-beta Peptide in Amyloid Precursor Protein Transgenic Mice: Implications for the Pathogenesis and Treatment of Alzheimers Disease. Proc. Natl. Acad. Sci. 2001, 98, 10273-10278. (Pubitemid 32803010)
31. Legleiter, J.; Czilli, D. L.; Gitter, B.; DeMattos, R. B.; Holtzman, D. M.; Kowalewski, T. Effect of Different anti-Aβ Antibodies on Aβ Fibrillogenesis as Assessed by Atomic Force Microscopy. J. Mol. Biol. 2004, 335, 997-1006. (Pubitemid 38091605)